BOSTON — Patients with COPD faced a decreased risk of severe cardiopulmonary events if treated with single inhaler vs. multiple inhaler triple therapy, according to data presented at the CHEST Annual Meeting. “These data continue to support the optimization of using single inhaler triple therapy with Breztri to proactively...